MOTS-c: Research Overview

MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial genome rather than the nuclear genome — a rare feature among known peptides. It is studied as a regulator of metabolic homeostasis and as a potential exercise mimetic.

Mitochondrial origin and AMPK activation

MOTS-c is encoded within the mitochondrial 12S rRNA gene, making it one of the few peptides of mitochondrial rather than nuclear origin. Its primary studied mechanism is activation of AMP-activated protein kinase (AMPK), a central cellular energy sensor, and the downstream factor TFAM (mitochondrial transcription factor A). Research published in Cell Metabolism (Lee et al., 2015) showed MOTS-c translocating to the nucleus under metabolic stress.

Metabolic and longevity research

Mouse studies have reported that MOTS-c administration improves insulin sensitivity, reduces high-fat-diet-induced obesity, and extends median lifespan in aged mice — effects that parallel those of exercise. Because circulating MOTS-c levels decline with age in humans, it is an active subject of longevity and metabolic-aging research.

Purity and verification

Pokai Research MOTS-c is third-party tested by Freedom Diagnostics Testing at 99.72% purity (batch 26030285), with a batch-specific COA and verification search code published on the product page.

Frequently asked questions

What is MOTS-c and how does it relate to mitochondrial signaling?

MOTS-c is a 16-amino-acid peptide encoded in the mitochondrial genome rather than the nuclear genome. It activates AMPK, a central energy-sensing enzyme. Mouse studies report improved insulin sensitivity, reduced diet-induced obesity, and extended median lifespan, making MOTS-c an active subject of longevity research.

Source: Cell Metab (2015) · PubMed

How does mitochondrial dysfunction relate to aging?

The mitochondrial theory of aging posits that cumulative damage to mitochondrial DNA, membranes, and respiratory chain complexes reduces ATP production efficiency and increases reactive oxygen species (ROS) generation over time. This creates a positive feedback loop: ROS damage mitochondrial components further, impairing energy production and accelerating cellular senescence. Research in model organisms has demonstrated that interventions restoring mitochondrial biogenesis (via PGC-1α activation), reducing electron leak, or enhancing mitophagy can extend healthy lifespan. Peptides targeting these mitochondrial pathways — including MOTS-c and SS-31 — are of active research interest in the context of aging biology.

Source: Cell (2013) · PubMed

What role does AMPK activation play in metabolic health and longevity research?

AMP-activated protein kinase (AMPK) is a heterotrimeric enzyme that acts as a cellular fuel gauge, activated when the AMP:ATP ratio rises (indicating energy deficit). Upon activation, AMPK inhibits anabolic processes (fatty acid synthesis, gluconeogenesis, protein synthesis) while stimulating catabolic pathways (fatty acid oxidation, autophagy, mitochondrial biogenesis). Pharmacological AMPK activators — including metformin and AICAR — extend lifespan in multiple model organisms. MOTS-c is among a small number of endogenous peptides that activate AMPK through a distinct retrograde mitochondrial signaling mechanism, placing it at the intersection of energy sensing and longevity pathways.

Source: Nat Rev Mol Cell Biol (2011) · PubMed

How is peptide purity measured and why does it matter?

Peptide purity is typically assessed by reverse-phase high-performance liquid chromatography (HPLC) and confirmed by mass spectrometry. These techniques quantify the proportion of the target compound relative to impurities such as deletion sequences, oxidized variants, or solvent residues. Research applications require high purity — commonly ≥98% — to ensure that observed biological effects can be attributed to the intended molecule rather than contaminants. Independent third-party certificates of analysis (COAs) provide an objective record of purity at the time of synthesis.

Source: J Pept Sci (2019) · PubMed

View MOTS-c in the catalog →